FDA approves NASH liver disease drug from Madrigal Pharmaceuticals
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket | Getty ImagesThe Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide.The FDA's decision means Madrigal Pharmaceuticals has succeeded in a disease area that several larger companies have failed — or are still trying to break into. Madrigal shares jumped more than 20% in…